Royal Bank of Canada’s GoodRx Holdings GDRX Stock Holding History
Bought
Maintained
Sold
Other funds holding GDRX
FPM
VCM
SLG
VPM
PTC
PGCM
Royal Bank of Canada's GDRX Position: Q1 2026 in Review
Royal Bank of Canada reduced its GoodRx Holdings (GDRX) stake by 31% in Q1 2026, selling an estimated $77.8K and leaving 75,243 shares worth $148K. The position accounts for ﹤0.01% of the portfolio, ranked #4900.
Royal Bank of Canada first reported a position in GDRX in Q3 2020 and has held it in 23 quarters since. The position peaked at $8.85M in Q1 2021. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.
- Royal Bank of Canada held 75,243 shares of GoodRx Holdings worth $148K as of Q1 2026.
- Royal Bank of Canada sold 33,169 GoodRx Holdings shares in Q1 2026, an estimated $77.8K.
- GoodRx Holdings made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #4900 holding.
- Royal Bank of Canada first reported a position in GoodRx Holdings in Q3 2020 and has held it in 23 quarters since.
- Royal Bank of Canada's GoodRx Holdings position peaked at $8.85M in Q1 2021.
- 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.